Quality Improvement Grants to enhance Patient-Centered Outcomes in United States
Section
The Pfizer and the American College of Emergency Physicians (ACEP) are collaborating to offer a new grant opportunity seeking proposals for quallity improvement initiatives that will promote the safe management of patients diagnosed with migraine in the emergency department setting.
They seek to support projects focused on clinical program development that overcome barriers to safe, evidence-based management, disposition, and follow up of this patient population. Funded projects will describe the proposed clinical initiative’s efficacy with outcome measures that demonstrate improved management of migraine patients, patient safety, physician satisfaction, and/or patient satisfaction.
Potential applicants are encouraged to pinpoint and tackle obstacles and deficiencies concerning migraine management in the emergency department (ED). This may include: Improving patient experience of ED care for patients with migraine; Outcomes associated with novel approaches to acute migraine treatment in the ED; Improving access to prompt follow-up with primary care providers.
Areas of Interests
- Primary Area of Interest:
- Migraine
- Specific Area of Interest for this RFP:
- It is their intent to support projects that focus on improving quality of care of patients with migraines in the emergency department setting, including, but not limited to, decreased cost, decreased length of stay, decreased return visits, improved pain control, improved time to pain control, or decreased testing.
- Multi-disciplinary collaborations, are encouraged when appropriate, but all partners must have a relevant role.
- It is expected that projects will be evidence-based (education and/or quality improvement) and the proposed research/evaluation will follow generally accepted scientific principles. During review the intended outcome of the project is given careful consideration and, if appropriate based on the project goal, projects with the maximum likelihood to directly impact patient care will be given high priority.
- There is a considerable amount of interest in receiving responses from projects that utilize systembased changes. Although educational efforts for grantees and patients may be entirely appropriate components in responses to this RFP, projects that include an overt description of system changes will be given high priority.
Funding Information
- Individual projects requesting up to $200,000 USD will be considered (inclusive of all direct, overhead, and in-direct cost). It is their intent to support 3 to 4 projects.
- Maximum project length is 2 years
Target Audience
- Emergency Physicians treating adult patients presenting with symptoms of migraine in the ED
Eligibility Criteria
- Geographic Scope:
- United States
- Applicant Eligibility Criteria
- The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations; government agencies; and other entities with a mission related to healthcare improvement.
- Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society).
- Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions / organizations / associations, are encouraged. Please note all partners must have a relevant role and the requesting organization must have a key role in the project.
- The applicant must be the Project Lead/Principal Investigator (PI) or an authorized designee of such individual (e.g., Project Lead/PI’s grant/research coordinator).
- The Project Lead/PI must be an employee or contractor of the requesting organization.
- Requesting organization must be legally able to receive award funding directly from Pfizer Inc. They strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer Inc. may be subject to rescission.
